Table 1

Participant characteristics (N=60)

Age, years, mean (SD)59.8 (6.2)
Female, n (%)39 (65.0)
Race/ethnicity, n (%)
 Non-Hispanic black35 (58.3)
 Non-Hispanic white19 (31.7)
 Hispanic4 (6.7)
 Asian/Pacific Islander2 (3.3)
Education, n (%)
 High school or less10 (16.7)
 Some college, associate degree, or technical programme24 (40.0)
 College degree or more26 (43.3)
Income, n (%)
 ≤$50 00024 (40.0)
 $50 000 to $100 00017 (28.3)
 >$100 00017 (28.3)
 Missing2 (3.3)
Diabetes duration, years, median (IQR)4.0 (3.5)
Diabetes medication duration, years, median (IQR)4.0 (3.0)
Hypertension duration, years, median (IQR)9.0 (7.5)
Hypertension medication duration, years, median (IQR)8.0 (7.8)
Glycated hemoglobin, per cent, mean (SD)7.0 (1.2)
Systolic blood pressure, mm Hg, mean (SD)133.9 (17.0)
Diastolic blood pressure, mm Hg, mean (SD)75.6 (11.5)
Number of diabetes medication, mean (SD)1.2 (0.5)
Number of hypertension medications, mean (SD)2.2 (1.0)
Likelihood of starting an additional diabetes pill*
 Very likely (≥7)43 (71.7)
 Somewhat likely (4–6)7 (11.7)
 Not likely (≤3)10 (16.7)
Likelihood of starting an additional hypertension pill*
 Very likely (≥7)41 (68.3)
 Somewhat likely (4–6)7 (11.7)
 Not likely (≤3)12 (20.0)
  • *Response scale options ranged from 1=‘not likely’ to 10=‘very likely’.